ORALMEDIC®  	ORALMEDIC®  	 NNP	B-NP
for  	for  	 IN	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
aphthous  	aphthous  	 JJ	B-NP
stomatitis--possible  	stomatitis--possible  	 JJ	I-NP
side  	side  	 NN	I-NP
effects  	effects  	 NNS	I-NP
with  	with  	 IN	O
repeated  	repeated  	 JJ	O
applications  	applications  	 NNS	B-NP
ORALMEDIC®  	ORALMEDIC®  	 VBP	O
( 	( 	 -LRB-	O
HybenX 	HybenX 	 NNP	B-NP
,  	,  	 ,	O
Epien  	Epien  	 NNP	B-NP
Medical  	Medical  	 NNP	I-NP
Inc. 	Inc. 	 NNP	O
,  	,  	 ,	O
Minneapolis 	Minneapolis 	 NNP	B-NP
,  	,  	 ,	O
MN 	MN 	 NNP	B-NP
,  	,  	 ,	O
USA 	USA 	 NNP	B-NP
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
a  	a  	 DT	O
relatively  	relatively  	 RB	O
recent  	recent  	 JJ	O
commercial  	commercial  	 JJ	B-NP
agent  	agent  	 NN	I-NP
designated  	designated  	 VBN	O
for  	for  	 IN	O
the  	the  	 DT	O
treatment  	treatment  	 NN	O
of  	of  	 IN	O
recurrent  	recurrent  	 FW	B-NP
aphthous  	aphthous  	 FW	I-NP
stomatitis  	stomatitis  	 FW	I-NP
( 	( 	 -LRB-	O
RAS 	RAS 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
It  	It  	 PRP	O
has  	has  	 VBZ	O
the  	the  	 DT	O
potential  	potential  	 JJ	O
to  	to  	 TO	O
safely  	safely  	 VB	O
and  	and  	 CC	O
effectively  	effectively  	 RB	O
reduce  	reduce  	 VB	O
pain  	pain  	 NN	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
RAS 	RAS 	 NNP	B-NP
.  	.  	 .	O
We  	We  	 PRP	O
present  	present  	 RB	O
two  	two  	 CD	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
used  	used  	 VBD	O
ORALMEDIC®  	ORALMEDIC®  	 CD	B-NP
to  	to  	 TO	O
reduce  	reduce  	 VB	O
pain  	pain  	 NN	O
caused  	caused  	 VBN	O
by  	by  	 IN	O
RAS  	RAS  	 NNP	B-NP
lesions 	lesions 	 NNS	I-NP
.  	.  	 .	O
Both  	Both  	 DT	O
patients  	patients  	 NNS	O
developed  	developed  	 VBN	B-NP
side  	side  	 NN	I-NP
effects  	effects  	 NNS	I-NP
presenting  	presenting  	 VBG	O
as  	as  	 IN	O
deep  	deep  	 JJ	O
ulcerations  	ulcerations  	 NN	O
with  	with  	 IN	O
a  	a  	 DT	O
necrotic  	necrotic  	 JJ	B-NP
base  	base  	 NN	I-NP
at  	at  	 IN	O
the  	the  	 DT	O
location  	location  	 NN	O
where  	where  	 WRB	O
ORALMEDIC®  	ORALMEDIC®  	 NNP	B-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
repeatedly  	repeatedly  	 RB	O
applied  	applied  	 VBN	O
as  	as  	 IN	O
pain  	pain  	 NN	O
did  	did  	 VBD	O
not  	not  	 RB	O
diminish  	diminish  	 VB	O
after  	after  	 IN	O
the  	the  	 DT	O
first  	first  	 JJ	O
application 	application 	 NN	O
.  	.  	 .	O
One  	One  	 CD	O
patient  	patient  	 NN	O
used  	used  	 VBD	O
ORALMEDIC®  	ORALMEDIC®  	 CD	B-NP
several  	several  	 JJ	O
times  	times  	 NNS	O
on  	on  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
lesion 	lesion 	 NN	B-NP
.  	.  	 .	O
However  	However  	 RB	O
the  	the  	 DT	O
other  	other  	 JJ	O
patient  	patient  	 NN	O
followed  	followed  	 VBD	O
the  	the  	 DT	O
manufacturer  	manufacturer  	 NN	B-NP
instructions  	instructions  	 NNS	I-NP
when  	when  	 WRB	O
he  	he  	 PRP	O
successively  	successively  	 VBP	O
used  	used  	 VBN	O
ORALMEDIC®  	ORALMEDIC®  	 RB	O
stick  	stick  	 VB	O
twice  	twice  	 RB	O
over  	over  	 IN	O
the  	the  	 DT	O
same  	same  	 JJ	O
lesion 	lesion 	 NN	B-NP
.  	.  	 .	O
Patients  	Patients  	 NNS	O
were  	were  	 VBD	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
systemic  	systemic  	 JJ	B-NP
antibiotics  	antibiotics  	 NN	I-NP
and  	and  	 CC	O
local  	local  	 JJ	O
antiseptic  	antiseptic  	 JJ	B-NP
agents 	agents 	 NNS	I-NP
.  	.  	 .	O
The  	The  	 DT	O
healing  	healing  	 NN	B-NP
process  	process  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
ulcers  	ulcers  	 NN	O
was  	was  	 VBD	O
slow  	slow  	 JJ	O
and  	and  	 CC	O
has  	has  	 VBZ	O
completed  	completed  	 VBN	O
its  	its  	 PRP$	O
course  	course  	 NN	O
within  	within  	 IN	O
six  	six  	 CD	O
weeks 	weeks 	 NNS	O
.  	.  	 .	O
It  	It  	 PRP	O
is  	is  	 VBZ	O
suggested  	suggested  	 VBN	O
that  	that  	 IN	O
when  	when  	 WRB	O
dental  	dental  	 JJ	B-NP
surgeons  	surgeons  	 NNS	I-NP
recommend  	recommend  	 VBP	O
ORALMEDIC® 	ORALMEDIC® 	 RB	O
,  	,  	 ,	O
they  	they  	 PRP	O
should  	should  	 MD	O
emphasize  	emphasize  	 VB	O
the  	the  	 DT	O
importance  	importance  	 NN	O
of  	of  	 IN	O
using  	using  	 VBG	O
this  	this  	 DT	O
agent  	agent  	 NN	B-NP
according  	according  	 VBG	O
to  	to  	 TO	O
the  	the  	 DT	O
manufacturer 	manufacturer 	 NN	O
's  	's  	 POS	O
instructions  	instructions  	 NNS	B-NP
in  	in  	 IN	O
order  	order  	 NN	O
to  	to  	 TO	O
minimize  	minimize  	 VB	O
the  	the  	 DT	O
risk  	risk  	 NN	O
for  	for  	 IN	O
side  	side  	 NN	B-NP
effects 	effects 	 NNS	I-NP
.  	.  	 .	O
